Stock Analysis on Net
Stock Analysis on Net

DexCom Inc. (NASDAQ:DXCM)

This company has been moved to the archive! The financial data has not been updated since October 26, 2023.

Balance Sheet: Assets
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

DexCom Inc., consolidated balance sheet: assets (quarterly data)

US$ in thousands

Microsoft Excel
Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018
Cash and cash equivalents 643,700 1,194,900 623,200 642,300 698,100 735,400 716,000 1,052,600 1,444,300 1,158,800 733,800 817,600 673,500 530,000 584,600 446,200 395,600 709,200 1,285,100 1,137,000 367,400 300,200 420,400
Short-term marketable securities 2,596,600 2,441,300 1,943,800 1,813,900 1,673,800 2,019,400 1,972,200 1,678,600 1,253,600 1,426,100 1,898,800 1,890,100 1,930,300 1,978,800 925,900 1,087,100 1,034,300 668,300 72,900 248,600 301,300 305,900 113,500
Accounts receivable, net 785,700 750,600 636,800 713,300 564,100 560,800 544,500 514,300 529,100 483,500 443,400 428,500 370,000 296,500 300,700 286,300 234,900 217,300 204,700 226,700 169,800 162,000 123,900
Inventory 498,600 421,100 366,000 306,700 311,000 339,500 342,200 357,300 351,300 319,300 289,700 234,700 200,700 165,300 141,900 119,800 120,400 117,900 101,100 70,700 55,200 46,200 51,600
Prepaid and other current assets 173,800 195,000 197,600 192,600 151,500 153,600 171,700 81,600 77,900 86,500 79,400 53,900 62,600 62,400 42,600 30,000 30,500 31,500 27,000 16,500 20,400 21,700 19,900
Current assets 4,698,400 5,002,900 3,767,400 3,668,800 3,398,500 3,808,700 3,746,600 3,684,400 3,656,200 3,474,200 3,445,100 3,424,800 3,237,100 3,033,000 1,995,700 1,969,400 1,815,700 1,744,200 1,690,800 1,699,500 914,100 836,000 729,300
Property and equipment, net 1,078,900 1,077,600 1,075,500 1,055,600 1,002,500 942,900 856,500 801,800 742,200 676,000 589,900 515,300 461,800 384,300 346,100 321,300 301,000 253,200 221,400 183,100 169,600 156,800 152,400
Operating lease right-of-use assets 73,400 76,300 78,000 80,000 73,100 77,900 82,300 88,100 91,300 94,800 98,800 93,300 94,300 71,600 73,800 71,500 34,600 35,800 27,700 — — — —
Goodwill 25,300 25,800 25,700 25,700 24,700 25,600 26,600 26,500 23,900 19,100 18,900 19,300 19,000 18,700 18,600 18,600 18,400 18,700 18,600 18,700 18,400 11,900 12,300
Intangibles, net 144,500 154,200 163,600 173,300 24,400 28,000 31,400 31,500 — — — — — — — — — — — — — — —
Deferred tax assets 501,300 417,000 349,100 341,200 342,300 309,500 290,800 220,800 216,300 216,400 216,700 216,400 — — — — — — — — — — —
Other assets 74,400 66,900 56,600 47,100 33,700 24,800 22,800 10,500 46,000 23,300 20,400 21,400 21,000 14,200 13,700 14,200 16,000 14,000 15,500 14,700 12,200 2,800 2,800
Non-current assets 1,897,800 1,817,800 1,748,500 1,722,900 1,500,700 1,408,700 1,310,400 1,179,200 1,119,700 1,029,600 944,700 865,700 596,100 488,800 452,200 425,600 370,000 321,700 283,200 216,500 200,200 171,500 167,500
Total assets 6,596,200 6,820,700 5,515,900 5,391,700 4,899,200 5,217,400 5,057,000 4,863,600 4,775,900 4,503,800 4,389,800 4,290,500 3,833,200 3,521,800 2,447,900 2,395,000 2,185,700 2,065,900 1,974,000 1,916,000 1,114,300 1,007,500 896,800

Based on: 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).

Assets: Selected Items

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. DexCom Inc. current assets increased from Q1 2023 to Q2 2023 but then slightly decreased from Q2 2023 to Q3 2023.
Property and equipment, net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. DexCom Inc. property and equipment, net increased from Q1 2023 to Q2 2023 and from Q2 2023 to Q3 2023.
Non-current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. DexCom Inc. non-current assets increased from Q1 2023 to Q2 2023 and from Q2 2023 to Q3 2023.
Total assets Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. DexCom Inc. total assets increased from Q1 2023 to Q2 2023 but then slightly decreased from Q2 2023 to Q3 2023.

Current Assets: Selected Items

Balance sheet item Description The company
Cash and cash equivalents Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. DexCom Inc. cash and cash equivalents increased from Q1 2023 to Q2 2023 but then slightly decreased from Q2 2023 to Q3 2023 not reaching Q1 2023 level.
Short-term marketable securities Amount of investment in marketable security, classified as current. DexCom Inc. short-term marketable securities increased from Q1 2023 to Q2 2023 and from Q2 2023 to Q3 2023.
Accounts receivable, net Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection. DexCom Inc. accounts receivable, net increased from Q1 2023 to Q2 2023 and from Q2 2023 to Q3 2023.
Inventory Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. DexCom Inc. inventory increased from Q1 2023 to Q2 2023 and from Q2 2023 to Q3 2023.